Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

Summary

The purpose of this study is to evaluate safety and pharmacokinetics as well as the biodistribution of OTSA101-DTPA-111In and to evaluate the safety of intravenous administration of OTSA101-DTPA-90Y.

Timeline

Start

2020-01-10

Primary completion

2024-01-11

Completion

2024-01-11

Outcome

Outcome not reported

Stopped: “Some of the raw materials for the investigational drug are difficult to obtain and expensive.”

Drugs

Indications